Addex Therapeutics Ltd. Annual Research And Development Expense in CHF from 2017 to 2023

Taxonomy & unit
ifrs-full: CHF
Summary
Addex Therapeutics Ltd. annual/quarterly Research And Development Expense history and growth rate from 2017 to 2023.
  • Addex Therapeutics Ltd. Research And Development Expense for the quarter ending June 30, 2023 was ₣1.88M, a 67.4% decline year-over-year.
  • Addex Therapeutics Ltd. annual Research And Development Expense for 2023 was ₣6.96M, a 52.5% decline from 2022.
  • Addex Therapeutics Ltd. annual Research And Development Expense for 2022 was ₣14.7M, a 14.2% increase from 2021.
  • Addex Therapeutics Ltd. annual Research And Development Expense for 2021 was ₣12.8M, a 23.8% increase from 2020.
Research And Development Expense, Annual (CHF)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 6.96M -7.7M -52.5% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-18
2022 14.7M +1.82M +14.2% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-18
2021 12.8M +2.47M +23.8% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-18
2020 10.4M -2.08M -16.7% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-30
2019 12.5M +7.54M +153% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
2018 4.92M +2.29M +87.1% Jan 1, 2018 Dec 31, 2018 20-F 2021-03-11
2017 2.63M Jan 1, 2017 Dec 31, 2017 20-F 2020-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.